Trap: Confusing mission objectives launch vehicles or technological capabilities. Examiners test precise technical terminology.
Most confused: The distinction between civilian and strategic (dual-use) technology and between indigenous development vs licensed production vs import.
Key anchor: The institutional architecture (ISRO DRDO DAE CSIR ICMR DBT MeitY) and policy framework (Space Policy Nuclear Doctrine Biotechnology Guidelines National AI Strategy Drone Rules).
Current affairs hook: Major missions (Chandrayaan-3 Aditya-L1 Gaganyaan) new policy initiatives (IN-SPACe iDEX Semiconductor Mission Quantum Mission AI Mission) defence tests (Agni S-400 ARIHANT) health tech (mRNA vaccines).
Mains hinge: Frame answers around the core tension - self-reliance vs international cooperation strategic autonomy vs technology access security vs transparency innovation vs regulation.
Core Concept
Biotechnology and Genetic Engineering represents India capabilities and aspirations in a strategic technology domain. It covers institutional architecture (ISRO DRDO DAE CSIR ICMR etc.) mission-mode programs indigenous development international cooperation and spin-off applications. For UPSC this topic tests awareness of recent missions technological milestones policy frameworks and societal implications.
The topic connects to economy (innovation startups IPR) IR (technology transfer export controls space diplomacy) security (dual-use tech missile tech) and ethics (AI ethics genetic editing nuclear safety). Government initiatives (Digital India Startup India Atmanirbhar Bharat) add policy dimension.
Key institutions: DBT (Department of Biotechnology) ICMR (Indian Council of Medical Research) CSIR (Council of Scientific and Industrial Research) ICAR (Indian Council of Agricultural Research) NII (National Institute of Immunology) CCMB (Centre for Cellular and Molecular Biology) IGIB (Institute of Genomics and Integrative Biology) NCBS (National Centre for Biological Sciences).
Major programs: National Biopharma Mission (2017-2024) Mission COVID Suraksha (2020) Genome India Project (2020) Biotechnology Industry Research Assistance Council (BIRAC) Make in India for Biotech (2014) National Biotech Development Strategy (2015-2020) and its successor (2021-2025).
Key Facts
key_institutions: DBT ICMR CSIR ICAR NII CCMB IGIB NCBS BIRAC
major_missions_programs: National Biopharma Mission Mission COVID Suraksha Genome India Project
technological_milestones: Indigenous COVID-19 vaccines (Covaxin ZyCoV-D) mRNA platform development recombinant insulin production BT cotton adoption gene editing research
policy_framework: National Biotechnology Development Strategy (2021-2025) Guidelines for Safety Assessment of Genome Edited Plants (2022) Recombinant DNA Safety Guidelines (1990 revised 2017) Drugs and Cosmetics Act Clinical Trials Rules
exam_relevance: Medium PYQ frequency tested in GS3
UPSC Question Themes (Illustrative)
Treat these as original practice prompts unless a linked official UPSC paper is provided; they are not represented as verbatim PYQs.
| Type | Stage | What was tested |
|---|---|---|
| Practice | Prelims | Genome India Project objectives and implementing agency |
| Practice | Mains | Challenges in indigenous vaccine development and regulatory framework |
| Practice | Prelims | Recombinant DNA technology applications in agriculture and medicine |
| Practice | Mains | Ethical concerns in gene editing and Indias regulatory preparedness |
| Practice | Prelims | BT cotton technology and regulatory approval process |
Statement Elimination Guide
Correct: "Biotechnology and Genetic Engineering has both civilian and strategic applications."
False: "Biotechnology and Genetic Engineering is purely a civilian domain with no security implications."
Trap: "India has achieved complete self-reliance in biotechnology and genetic engineering." (False. Critical components materials and high-end tech still require imports/cooperation.)
Correct: "DBT ICMR CSIR plays the lead role in biotechnology and genetic engineering."
False: "Private sector has no role in biotechnology and genetic engineering." (False. BIRAC startup ecosystem and industry partnerships are changing this.)
Current Affairs Hook
Genome India Project (10000 whole genome sequencing completed 2024) Mission COVID Suraksha (Covaxin ZyCoV-D Corbevax indigenously developed) National Biopharma Mission (BIRAC implementing 250+ projects) mRNA vaccine platform development (Gennova Biopharmaceuticals first Indian mRNA vaccine candidate 2022) Guidelines for Safety Assessment of Genome Edited Plants (2022) exempting SDN-1 and SDN-2 from GMO regulations Biotechnology Industry Research Assistance Council (BIRAC) 10th anniversary 2022 International collaborations: Quad vaccine partnership Indo-US Vaccine Action Program renewal 2023 Indo-EU Horizon Europe association.
Interlinkages
Science & Tech (Primary): Core subject coverage
GS Papers: Connects to GS3 primarily with spillovers to other GS papers
Current Affairs: Dynamic dimension through 2023-24 developments
Essay: Thematic material for governance democracy development federalism technology ethics